ReviewElectrolyte & blood pressure : E & BP2026
Overcorrection of Hyponatremia: A Complicated Story.
Review in Electrolyte & blood pressure : E & BP, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Overcorrection is a frequently encountered issue in the treatment of severe hyponatremia, which is defined as a serum sodium concentration below 120-125 mmol/L in symptomatic patients. Severe hyponatremic symptoms, including persistent vomiting, cardiorespiratory arrest, seizures, and reduced consciousness, clearly indicate the use of hypertonic (e.g., 3%) saline infusion to immediately elevate serum sodium levels. In the chronic phase, however, overcorrection is a major concern because an overly rapid increase in serum sodium concentration is an important cause of osmotic demyelination syndrome (ODS). Although risk groups for ODS are well known, saline infusion and water diuresis are 2 common factors underlying the overcorrection of hyponatremia. We propose that isotonic saline initially be infused (1 mL/kg/h) when encountering hyponatremic patients with moderately severe symptoms, such as confusion, headache, or nausea. Although this empirical therapy may not be consistent with current guidelines, it may reduce the risk of overcorrection and be effective in cases with unrecognized hypovolemia or waning vasopressin hyperactivity. We believe that hypertonic saline should be reserved for patients with severely symptomatic hyponatremia. In practice, urine sodium and osmolality should then be measured, along with follow-up serum sodium levels. Subsequent intravenous fluids can be selected according to the response of serum sodium levels and the differential diagnosis of hyponatremia. Because water diuresis is a critical contributor to overcorrection, urine output and urine sodium, potassium, and osmolality should be monitored during fluid therapy. Appropriate use of 5% dextrose in water and/or desmopressin may be necessary to re-lower serum sodium levels.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.